Cocrystal Pharma, Inc. · NASDAQ:COCP
Phillip Frost, M.D. reported a 10.60% stake in Cocrystal Pharma, Inc. (Schedule 13D/A)
Event Sep 30, 2025 · Filed Oct 2, 2025
Phillip Frost, M.D. reported a 10.60% stake in Cocrystal Pharma, Inc., 1,382,873 shares, with active intent on Sep 30, 2025. Filed Oct 2, 2025 (Schedule 13D/A).
- Stake
- 10.60%
- Shares
- 1,382,873
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Phillip Frost, M.D. | 10.60% | 1,382,873 |
| Frost Gamma Investments Trust | 10.10% | 1,319,838 |
Source
Related
- Cocrystal Pharma, Inc.
- Frost Gamma Investments Trust
- Cocrystal Pharma, Inc. shareholders
- Schedule 13D/A · Frost Gamma Investments Trust · Aug 7, 2026
- Schedule 13D/A · Frost Gamma Investments Trust · Oct 30, 2025
- Schedule 13D · Opko Health, Inc. · Aug 7, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 6, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 5, 2026